2026 NPPES data Otolaryngic Allergy Physician NPI 1275988313 MD
Verify on CMS →

JORDAN MALENKE, MD

Otolaryngic Allergy Physician in SCARBOROUGH, Maine. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
351
Medicare Part D claims · 109 beneficiaries · Otolaryngic Allergy Physician avg: 788
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.0699/100
▲ 15 pts above national avg 83.1 · [object Object]

What the federal data shows

JORDAN MALENKE, MD reported a CMS MIPS final score of 98.0699/100 — above the 83.1 national average — and filed 351 Medicare Part D claims in 2023.

98.0699/100
MIPS score · +15 vs avg
351
Part D claims, 2023
97%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JORDAN MALENKE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

98 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JORDAN MALENKE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JORDAN MALENKE, MD?

High performer (top quartile)

NPI registry status

Active

Issued 04/26/2016

NPI 1275988313

Primary specialty

Otolaryngic Allergy Physician

Rare

151 US NPIs in this specialty

Medicare Part D claims

351 55% vs specialty avg

2023 prescription claims

Specialty avg: 788

MIPS final score

98.0699/100 14.96990000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Maine

How Otolaryngic Allergy Physician compares to other specialties among Maine providers

Maine providers

Otolaryngic Allergy Physician share within Maine

1. Otolaryngic Allergy Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngic Allergy Physician share within Maine

Medicare quality performance — MIPS

JORDAN MALENKE, MD's 2023 MIPS final score plotted against the Otolaryngic Allergy Physician national average

High performer (top quartile)
MIPS Final Score
98.0699/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otolaryngic Allergy Physician) — 98.0699/100 vs national avg 83.1

0%100%National avg83%98.1%
MIPS final score (Otolaryngic Allergy Physician) — 98.0699/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JORDAN MALENKE, MD appears in the CMS NPPES registry as a Otolaryngic Allergy Physician provider holding MD credentials at 92 CAMPUS DR FL 3, SCARBOROUGH, ME, 04074, with a listed phone of (207) 797-5753. NPI 1275988313 was issued on 04/26/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MALENKE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 351 prescription claims written by this provider, covering 109 Medicare beneficiaries and totaling roughly $15K in drug spend, split 3% brand-name and 97% generic by claim count, with an opioid prescribing rate of 10.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.0699/100 for the 2023 performance year (Quality 86.1398), compared with the national average of 83.1.

Otolaryngic Allergy Physician is a narrow specialty nationwide, with 151 enrolled providers across 38 states and an average of 788 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

92 CAMPUS DR FL 3
SCARBOROUGH, ME 04074

Provider Details

NPI 1275988313
Specialty Otolaryngic Allergy Physician
Credentials MD
Gender Male
NPI Issued 04/26/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.0699
Final Score
Avg: 83.1
86.1398
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where JORDAN MALENKE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MAINEHEALTH
BIDDEFORD, ME

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Generic-heavy

JORDAN MALENKE, MD — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 351 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

351
Total Claims
$15K
Total Drug Cost
109
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
389
Total Day Supply
6,585
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$9K
Generic Drug Cost
$7K
Opioid Claims
37 (10.5% rate)
Antibiotic Claims
39

Patient Demographics

Average Patient Age
70.1 years
Avg HCC Risk Score
1.23
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JORDAN MALENKE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ipratropium Bromide
47
Oxycodone Hcl
36
Ondansetron Odt
Ondansetron
32
Azelastine Hcl
25
Prednisone
24
Lidocaine Hcl Viscous
Lidocaine Hcl
22
Doxycycline Hyclate
15
Fluticasone Propionate
14
Gabapentin
13
Mupirocin
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngic Allergy Physician Overview

How JORDAN MALENKE, MD fits within the Otolaryngic Allergy Physician landscape nationally.

151
Otolaryngic Allergy Physician Providers in US
38
States with Otolaryngic Allergy Physician
788
Avg Claims per Provider

JORDAN MALENKE, MD's 351 claims are below the specialty average of 788.

Frequently Asked Questions

What is JORDAN MALENKE, MD's specialty?
JORDAN MALENKE, MD specializes in Otolaryngic Allergy Physician and practices in SCARBOROUGH, Maine. Credentials: MD.
How much does JORDAN MALENKE, MD prescribe under Medicare Part D?
In 2023, JORDAN MALENKE, MD wrote 351 Medicare Part D claims totaling $15K in drug costs for 109 beneficiaries.
What is JORDAN MALENKE, MD's Medicare quality score?
JORDAN MALENKE, MD has a CMS MIPS Final Score of 98.0699/100 (Quality: 86.1398). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JORDAN MALENKE, MD located?
JORDAN MALENKE, MD is located at 92 CAMPUS DR FL 3, SCARBOROUGH, ME, 04074. Phone: (207) 797-5753.
What is JORDAN MALENKE, MD's NPI number?
JORDAN MALENKE, MD's National Provider Identifier (NPI) is 1275988313, issued on 04/26/2016.
Does JORDAN MALENKE, MD prescribe more brand-name or generic drugs?
JORDAN MALENKE, MD's prescribing is 3% brand-name and 97% generic drugs by claim count, with $9K in brand drug costs.
Does JORDAN MALENKE, MD prescribe opioids?
Yes, JORDAN MALENKE, MD had 37 opioid claims in 2023 with an opioid prescribing rate of 10.5%.
How many Otolaryngic Allergy Physician providers are there in the US?
There are 151 Otolaryngic Allergy Physician providers across 38 states in the US. The average Otolaryngic Allergy Physician provider writes 788 Medicare Part D claims per year.
What drugs does JORDAN MALENKE, MD prescribe most often?
Based on 2023 Medicare Part D data, JORDAN MALENKE, MD's most frequently prescribed drugs include Ipratropium Bromide, Oxycodone Hcl, Ondansetron Odt. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JORDAN MALENKE, MD accept Medicare?
JORDAN MALENKE, MD appears in CMS Medicare data with 351 Part D claims and 109 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JORDAN MALENKE, MD's credentials?
JORDAN MALENKE, MD's NPI is 1275988313 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology